Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Abstract Text:

Michael W Kattan,Michael W Kattan,

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Publishing Authors By Initials

MW Kattan,MW Kattan,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European urology

VOLUME: 52

Page Numbers: 1528

Journal Abbreviation: Eur. Urol.

ISSN: 0302-2838

DAY: 5

MONTH: Nov

YEAR: 2007

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 7512719

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.

AFFILIATION: Department of Quantitative Health Sciences, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland Clinic 44195, USA. kattanm@ccf.org

Country: Switzerland

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur Urol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score Partin Tables based on cases from 2000 to 2005 Related Publications

• A Decision analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
• A nomogram for predicting 10-year life expectancy in men with prostate cancer after definitive therapy.
• An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram.
• Angiographic confirmation of normal pleural thickness in right-upper-lobe collapse.
• Backward "displacement" of the spinolaminal line at C2: a normal variation.
• Child abuse and neglect: Perspective from King Faisal Specialist Hospital and Research Centre.
• Child abuse in Saudi Arabia: Report of ten cases.
• Childhood immunization in the Kingdom of Saudi Arabia.
• Editorial comment.
• Hydatid cysts in pancreas.
• Migration of central venous catheters.
• Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy.
• Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma.
• Nomograms are difficult to beat.
• Predicting Prostate Cancer Behavior-What is a Urologist to Do?
• Predicting an optimal outcome after radical prostatectomy: the trifecta nomogram.
• Preoperative nomogram predicting 12-year probability of metastatic renal cancer.
• Prostate volume measured preoperatively predicts for organ-confined disease in men with clinically localized prostate cancer.
• Re: Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy gleason score (Partin Tables) based on cases from 2000 to 2005.
• Sarcoma nomogram: validation and a model to evaluate impact of therapy.
• Second colon cancer following Hodgkin's disease. A case report.
• Sitting on the fence in x-ray reporting.
• Systematic review of statistical methods used in molecular marker studies in cancer.
• The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy.
• The addition of adrenaline to thoracic epidural meperidine does not improve analgesia following thoracotomy: [L'ajout d'adrenaline a la meperidine peridurale thoracique n'ameliore pas l'analgesie a la suite d'une thoracotomie].
• The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
• The notched articular process of C7 (dorsalization of C7).
• The role of societal benefits and fairness concerns among decision makers and decision recipients.
• Two features of the atlas vertebra simulating fractures by tomography.
• [Not Available.]